185 related articles for article (PubMed ID: 6795660)
1. Antagonism of oxotremorine-induced behavioral suppression by antimuscarinic drugs.
Leander JD
Psychopharmacology (Berl); 1981; 75(1):5-8. PubMed ID: 6795660
[TBL] [Abstract][Full Text] [Related]
2. Central and peripheral muscarinic actions of physostigmine and oxotremorine on avoidance responding of squirrel monkeys.
Witkin JM
Psychopharmacology (Berl); 1989; 97(3):376-82. PubMed ID: 2497488
[TBL] [Abstract][Full Text] [Related]
3. Effects of selective central muscarinic blockade on schedule-controlled behavior and on the rate-decreasing effects of physostigmine.
Hymowitz N; Brezenoff HE
Pharmacol Biochem Behav; 1984 Jul; 21(1):109-15. PubMed ID: 6463084
[TBL] [Abstract][Full Text] [Related]
4. Centrally active antimuscarinic analogs of oxotremorine selectively block physostigmine-induced hypertension, but not peripheral muscarinic vasodepression.
Vargas HM; Ringdahl B
J Pharmacol Exp Ther; 1990 Apr; 253(1):165-70. PubMed ID: 2329503
[TBL] [Abstract][Full Text] [Related]
5. Behavioral effects of some diphenyl-substituted antimuscarinics: comparison with cocaine and atropine.
Witkin JM; Genovese RF; Witkin KM; Chiang PK
Pharmacol Biochem Behav; 1992 Feb; 41(2):377-84. PubMed ID: 1574528
[TBL] [Abstract][Full Text] [Related]
6. Central oxotremorine antagonist properties of pirenzepine.
Witkin JM; Alvarado-Garcia R; Perez LA; Witkin KM
Life Sci; 1988; 42(24):2467-73. PubMed ID: 3374266
[TBL] [Abstract][Full Text] [Related]
7. Relationship of the behavioral effects of aprophen, atropine and scopolamine to antagonism of the behavioral effects of physostigmine.
Genovese RF; Elsmore TF; Witkin JM
Pharmacol Biochem Behav; 1990 Sep; 37(1):117-22. PubMed ID: 2263653
[TBL] [Abstract][Full Text] [Related]
8. Nonmuscarinic neurotoxicity of oxotremorine.
Witkin JM; Alvarado-Garcia R; Lee MA; Witkin KM
J Pharmacol Exp Ther; 1987 Apr; 241(1):34-41. PubMed ID: 3572794
[TBL] [Abstract][Full Text] [Related]
9. Effects of muscarinic receptor agonists and antagonists on alpha 2-adrenoceptors in rat brain.
Hollingsworth PJ; Smith CB
Eur J Pharmacol; 1989 Sep; 168(2):159-67. PubMed ID: 2558024
[TBL] [Abstract][Full Text] [Related]
10. Anticholinergic behavioral effect of phencyclidine.
Glick SD; Cox RD; Maayani S; Meibach RD
Eur J Pharmacol; 1979 Oct; 59(1-2):103-6. PubMed ID: 510389
[TBL] [Abstract][Full Text] [Related]
11. Microwave facilitation of methylatropine antagonism of central cholinomimetic drug effects.
Quock RM; Fujimoto JM; Ishii TK; Lange DG
Radiat Res; 1986 Mar; 105(3):328-40. PubMed ID: 3961098
[TBL] [Abstract][Full Text] [Related]
12. Chronic exercise produces tolerance to muscarinic antagonists in rats.
McMaster SB; Carney JM
Pharmacol Biochem Behav; 1986 Apr; 24(4):865-8. PubMed ID: 3714778
[TBL] [Abstract][Full Text] [Related]
13. Comparison of affinities of muscarinic antagonists to pre- and postjunctional receptors in the guinea-pig ileum.
Kilbinger H; Halim S; Lambrecht G; Weiler W; Wessler I
Eur J Pharmacol; 1984 Aug; 103(3-4):313-20. PubMed ID: 6489444
[TBL] [Abstract][Full Text] [Related]
14. Comparison of in vitro actions with behavioral effects of antimuscarinic agents.
Witkin JM; Gordon RK; Chiang PK
J Pharmacol Exp Ther; 1987 Sep; 242(3):796-803. PubMed ID: 3498817
[TBL] [Abstract][Full Text] [Related]
15. Behavioral effects of phenylpiperidine narcotic antagonists.
Leander JD
Pharmacol Biochem Behav; 1981 Jul; 15(1):65-70. PubMed ID: 7291232
[TBL] [Abstract][Full Text] [Related]
16. Oxotremorine antagonism by prolyl-leucyl-glycine-amide administered by different routes and with several anticholinergics.
Plotnikoff NP; Kastin AJ
Pharmacol Biochem Behav; 1974 May; 2(3):417-9. PubMed ID: 4837910
[No Abstract] [Full Text] [Related]
17. Characterization of the scopolamine stimulus in rats.
Jung M; Perio A; Worms P; Biziere K
Psychopharmacology (Berl); 1988; 95(2):195-9. PubMed ID: 3137597
[TBL] [Abstract][Full Text] [Related]
18. Behavioural tolerance to arecoline in rats: cross-tolerance to oxotremorine and prevention by pretreatment with atropine.
Overstreet DH; Jamal OS
Psychopharmacology (Berl); 1986; 89(1):118-20. PubMed ID: 3090586
[TBL] [Abstract][Full Text] [Related]
19. Glucose utilization in the Papez circuit: effects of oxotremorine and scopolamine.
Dam M; London ED
Brain Res; 1984 Mar; 295(1):137-44. PubMed ID: 6713172
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic discrimination between receptor heterogeneity and allosteric interaction: resultant analysis of gallamine and pirenzepine antagonism of muscarinic responses in rat trachea.
Kenakin T; Boselli C
J Pharmacol Exp Ther; 1989 Sep; 250(3):944-52. PubMed ID: 2778720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
